Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
J Clin Med ; 12(21)2023 Oct 29.
Article in English | MEDLINE | ID: mdl-37959297

ABSTRACT

Although the level of physical activity in daily life (PADL) plays a vital role concerning the health of subjects with chronic lung diseases, it remains uncertain how PADL patterns compare among different conditions. This study's objective was to compare the PADL levels of subjects with COPD, asthma and idiopathic pulmonary fibrosis (IPF); and to investigate PADL behaviour in different diseases' severity. Stable subjects who had not undergone pulmonary rehabilitation in the previous year were included. Subjects were divided into two subgroups according to disease severity: mild/moderate and severe/very severe. The primary outcome was time spent in moderate-to-vigorous physical activities (MVPA) (Actigraph GT3x) measured during one week over 12 h/day; other assessments included pulmonary function, peripheral muscle strength and exercise capacity. Comparisons among subgroups were corrected for age, BMI and sex. The analysis involved 119 subjects (47 asthma, 48 COPD and 24 IPF). Subjects with asthma had higher PADL levels than those with COPD and IPF (MVPA 18(14-22) vs. 8(4-12) vs. 7(1-12) min/day, respectively; p ancova = 0.002). Subjects with severe/very severe IPF had the lowest PADL level among all subgroups. Adult subjects with asthma have higher PADL levels than those with COPD and IPF, whereas patients with severe and very severe IPF are the most physically inactive subjects.

2.
ERJ Open Res ; 9(4)2023 Jul.
Article in English | MEDLINE | ID: mdl-37650084

ABSTRACT

Objective: The objective of the present study was to define the minimum number of monitoring days required for the adequate cross-sectional assessment of sedentary behaviour in individuals with chronic obstructive pulmonary disease (COPD). Methods: In this cross-sectional study, the sedentary behaviour of individuals with COPD was assessed using two physical activity monitors during awake time for seven consecutive days. Time spent per day in activities requiring ≤1.5 metabolic equivalents (METs) and in sitting, lying and sitting+lying positions was calculated taking into account the average of 7 days (as a reference in all analyses) and of all 119 possible combinations of 2---6 days. Intraclass correlation coefficients (ICCs) and linear regression analyses were performed for all combinations. Results: 91 individuals were analysed (47 female, 66±9 years, forced expiratory volume in 1 s 50±15% predicted). For the variables time spent per day in activities ≤1.5METs and sitting, the average of any combination of at least four assessment days was sufficient to adequately reflect the average of 7 days (adjusted R2≥0.929, ICC≥0.962, p<0.0001 for all). For time spent per day lying and sitting+lying, only two assessment days were enough (adjusted R2≥0.937, ICC≥0.968, p<0.0001 for all). Results were maintained independently of patient sex, disease severity, day of the week, daylight time or daytime naps. Conclusions: The average of 4 days of objective monitoring was sufficient to adequately reflect the results of a 1-week assessment of the main outcomes related to sedentary behaviour in individuals with moderate to very severe COPD, regardless of sex, disease severity, day of the week, daylight time and occurrence of daytime naps.

3.
COPD ; 20(1): 162-166, 2023 12.
Article in English | MEDLINE | ID: mdl-37166420

ABSTRACT

The association between physical activity in daily life (PADL) and simple functional tests is not yet clearly understood in subjects with chronic obstructive pulmonary disease (COPD). Therefore, the aim of this study was to investigate the association of two functional tests (Sit-to-Stand test [STS] and the 4-Metre Gait Speed test [4MGS]) with PADL, as well as to identify whether these tests can discriminate those subjects who are physically inactive. In this cross-sectional study, 28 subjects with COPD performed the five repetitions Sit-to-Stand (STS5r), the 4MGS and used the DynaPort activity monitor for 7 days in order to assess PADL. Walking time, movement intensity while walking (MI) and Physical Activity Level index (PAL) were considered as PADL outcomes. STS5r and 4MGS, respectively, were significantly associated with walking time (R2 = 0.16; p = 0.024 and R2 = 0.25; p = 0.006) and PAL index (R2 = 0.17; p = 0.002 and R2 = 0.30; p = 0.003), whereas movement intensity was associated only with the 4MGS (R2 = 0.23; p = 0.009). Additionally, both tests were able to discriminate physically inactive subjects (cutoffs: STS5r = 11.48s [AUC = 0.73]; 4MGS = 1.09m/s [AUC = 0.88]). In conclusion, STS5r and 4MGS can predict up to 30% of PADL in subjects with COPD. Both tests are related to PADL duration (e.g. time spent walking), while only the 4MGS reflects movement intensity. Both tests presented discriminative capacity to identify subjects with worse PADL pattern.


Subject(s)
Pulmonary Disease, Chronic Obstructive , Humans , Cross-Sectional Studies , Exercise , Walking , Exercise Test
4.
J Bras Pneumol ; 48(4): e20210412, 2022.
Article in English, Portuguese | MEDLINE | ID: mdl-36074407

ABSTRACT

OBJECTIVE: To evaluate sleep-onset time variability, as well as sleep characteristics on weekday and weekend nights, in individuals with moderate-to-severe COPD. METHODS: Sleep was objectively assessed by an activity/sleep monitor for seven consecutive nights in individuals with COPD. For analysis, individuals were divided into two groups according to sleep-onset time variability results, characterized by intrasubject standard deviation of sleep-onset time (SOTV) ≥ 60 min or < 60 min. RESULTS: The sample comprised 55 individuals (28 males; mean age = 66 ± 8 years; and median FEV1 % of predicted = 55 [38-62]). When compared with the SOTV<60min group (n = 24), the SOTV≥60min group (n = 31) presented shorter total sleep time (5.1 ± 1.3 h vs. 6.0 ± 1.3 h; p = 0.006), lower sleep efficiency (73 ± 12% vs. 65 ± 13%; p = 0.030), longer wake time after sleep onset (155 ± 66 min vs. 115 ± 52 min; p = 0.023), longer duration of wake bouts (19 [16-28] min vs. 16 [13-22] min; p = 0.025), and higher number of steps at night (143 [104-213] vs. 80 [59-135]; p = 0.002). In general, sleep characteristics were poor regardless of the day of the week, the only significant difference being that the participants woke up about 30 min later on weekends than on weekdays (p = 0.013). CONCLUSIONS: Sleep-onset time varied over 1 h in a standard week in the majority of individuals with COPD in this sample, and a more irregular sleep onset indicated poor sleep quality both on weekdays and weekends. Sleep hygiene guidance could benefit these individuals if it is integrated with their health care.


Subject(s)
Pulmonary Disease, Chronic Obstructive , Sleep , Aged , Humans , Male , Middle Aged , Polysomnography , Time Factors
5.
J. bras. pneumol ; 48(4): e20210412, 2022. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1405410

ABSTRACT

ABSTRACT Objective: To evaluate sleep-onset time variability, as well as sleep characteristics on weekday and weekend nights, in individuals with moderate-to-severe COPD. Methods: Sleep was objectively assessed by an activity/sleep monitor for seven consecutive nights in individuals with COPD. For analysis, individuals were divided into two groups according to sleep-onset time variability results, characterized by intrasubject standard deviation of sleep-onset time (SOTV) ≥ 60 min or < 60 min. Results: The sample comprised 55 individuals (28 males; mean age = 66 ± 8 years; and median FEV1 % of predicted = 55 [38-62]). When compared with the SOTV<60min group (n = 24), the SOTV≥60min group (n = 31) presented shorter total sleep time (5.1 ± 1.3 h vs. 6.0 ± 1.3 h; p = 0.006), lower sleep efficiency (73 ± 12% vs. 65 ± 13%; p = 0.030), longer wake time after sleep onset (155 ± 66 min vs. 115 ± 52 min; p = 0.023), longer duration of wake bouts (19 [16-28] min vs. 16 [13-22] min; p = 0.025), and higher number of steps at night (143 [104-213] vs. 80 [59-135]; p = 0.002). In general, sleep characteristics were poor regardless of the day of the week, the only significant difference being that the participants woke up about 30 min later on weekends than on weekdays (p = 0.013). Conclusions: Sleep-onset time varied over 1 h in a standard week in the majority of individuals with COPD in this sample, and a more irregular sleep onset indicated poor sleep quality both on weekdays and weekends. Sleep hygiene guidance could benefit these individuals if it is integrated with their health care.


RESUMO Objetivo: Avaliar a variabilidade do tempo de início do sono, bem como as características do sono durante a semana e o fim de semana, em indivíduos com DPOC moderada a grave. Métodos: O sono foi avaliado objetivamente por meio de um monitor de atividade/sono durante sete noites consecutivas em indivíduos com DPOC. Para a análise, os indivíduos foram divididos em dois grupos, de acordo com a variabilidade do tempo de início do sono, caracterizada pelo desvio-padrão do tempo de início do sono (TISV) ≥ 60 min ou < 60 min em um mesmo indivíduo. Resultados: A amostra foi composta por 55 indivíduos [28 homens; média de idade = 66 ± 8 anos; mediana do VEF1 em % do previsto = 55 (38-62)]. Em comparação com o grupo TISV<60min (n = 24), o grupo TISV≥60min (n = 31) apresentou menor tempo total de sono (5,1 ± 1,3 h vs. 6,0 ± 1,3 h; p = 0,006), menor eficiência do sono (73 ± 12% vs. 65 ± 13%; p = 0,030), maior tempo de vigília após o início do sono (155 ± 66 min vs. 115 ± 52 min; p = 0,023), blocos de vigília mais longos [19 (16-28) min vs. 16 (13-22) min; p = 0,025] e maior número de passos dados à noite [143 (104-213) vs. 80 (59-135); p = 0,002]. Em geral, as características do sono foram ruins independentemente do dia da semana; a única diferença significativa foi que os participantes acordaram cerca de 30 min mais tarde nos fins de semana do que nos dias de semana (p = 0,013). Conclusões: O tempo de início do sono variou mais de 1 h em uma semana-padrão na maioria dos indivíduos com DPOC da amostra, e um início de sono mais irregular indicou má qualidade do sono tanto nos dias de semana como nos fins de semana. A orientação a respeito da higiene do sono pode ser benéfica se for integrada à atenção à saúde desses pacientes.

6.
COPD ; 18(3): 299-306, 2021 06.
Article in English | MEDLINE | ID: mdl-33961519

ABSTRACT

Muscle dysfunction is one of the main features in individuals with chronic obstructive pulmonary disease (COPD). Handgrip strength (HS) has been used as a representation of general muscle strength in various populations, and a few studies found correlation between HS and other measures of upper and lower limbs' muscle strength in the general population, although this was not yet studied in depth in COPD. The aims of this study were to verify if HS is cross-sectionally well correlated with upper and lower limbs' muscle strength in individuals with COPD, and to identify a new cutoff for handgrip weakness in this population. HS was assessed by a dynamometer, whereas other muscle strength assessments comprised maximal voluntary contraction (MVC) of the quadriceps femoris and 1-repetition maximum (1RM) of biceps and triceps brachii, pectoralis major, latissimus dorsi and quadriceps femoris. Additional assessments included pulmonary function and volumes, body composition and exercise capacity. Fifty individuals with COPD were studied (65 ± 7 years; FEV1 51 ± 14%pred). HS showed moderate-to-strong correlations with all 1-RM assessments (0.62

Subject(s)
Hand Strength , Pulmonary Disease, Chronic Obstructive , Female , Humans , Lung , Male , Muscle Strength , Muscle, Skeletal , Quadriceps Muscle
7.
COPD ; 17(6): 623-626, 2020 12.
Article in English | MEDLINE | ID: mdl-33238759

ABSTRACT

Increasing physical activity (PA) is a complex and challenging task in patients with chronic obstructive pulmonary disease (COPD). However, some questions are raised regarding the evaluation of PA in these patients: Have all aspects of PA evaluation in patients with COPD already been explored in the scientific literature and clinical practice? What is the clinical importance of assessing PA inequality? PA inequality is defined as the Gini coefficient (Ginicoef) of the PA distribution of a population and is already shown to have implications for public health in the general population. It is a simple tool that might allow a better understanding of PA disparities among different COPD populations, although to our knowledge there is no previous investigation of PA inequality in patients with COPD using the Ginicoef. In this perspective study we have provided examples of the Ginicoef use in different scenarios. Future studies might try to apply it in order to identify subpopulations with higher PA inequality, and perhaps are therefore more prone to benefit most from interventions specifically tailored to promote PA. In summary, we propose the quantification of PA inequality with the Ginicoef as a tool that might allow us to see PA even more comprehensively than we already do, expanding our perspective on PA in patients with COPD.


Subject(s)
Exercise , Pulmonary Disease, Chronic Obstructive/physiopathology , Humans
8.
ERJ Open Res ; 6(4)2020 Oct.
Article in English | MEDLINE | ID: mdl-33447609

ABSTRACT

The association between characteristics of sleep and physical activity in daily life (PADL) has not yet been investigated in depth in subjects with COPD. This study evaluated whether time spent per day in physical activity (PA) and sedentary behaviour are associated with sleep quantity and quality in this population. Sleep and PADL were objectively assessed by an activity monitor for 7 days and analysed on a minute-by-minute basis. Subjects also underwent spirometry and 6-min walking test (6MWT). Fifty-five subjects with moderate-to-severe COPD (28 male, 67±8 years) were studied. Subjects with total time in bed (TIB) per night ≥9 h had higher wake-after-sleep onset than TIB 7-9 h and TIB ≤7 h (195 (147-218) versus 117 (75-167) and 106 (84-156) min) and more fragmented sleep than TIB ≤7 h (8.2 (6.7-14.3) versus 6.3 (5.6-6.9) sleeping bouts; p<0.05 for all). Subjects with TIB ≥9 h also spent more time per day in sedentary behaviour and less time per day in PA of light and moderate-to-vigorous intensity than those with TIB 7-9 h and ≤7 h. In multiple linear regression, TIB ≥9 h was the only significant predictor of physical inactivity (ß=-3.3 (-5.1, -1.6), p≤0.0001), accounting for 20% of its variation. Sleep fragmentation was frequent and more pronounced in physically inactive than active patients (7.5 (6.3-9.6) versus 6.4 (5.5-7.3) sleeping bouts; p=0.027). In summary, subjects with COPD with TIB ≥9 h·night-1 have more fragmented sleep, are more sedentary and less physically active than those with <9 h·night-1, independently of the awake time. Sleep quality is frequently poor and even worse in patients classified as physically inactive.

9.
Lung ; 198(1): 135-141, 2020 02.
Article in English | MEDLINE | ID: mdl-31873783

ABSTRACT

PURPOSE: This study aimed to investigate whether patients with chronic obstructive pulmonary disease (COPD) presenting asthma overlap (ACO) benefit similarly in comparison to patients with only COPD after a 12-week high-intensity exercise training (ET) program. METHODS: Subjects with a diagnosis of COPD alone or ACO were evaluated and compared before and after a high-intensity ET program composed of walking and cycling plus strengthening exercises of the upper and lower limbs (3 days/week, 3 months, 36 sessions). Assessments included spirometry, bioelectrical impedance, 6-min walk test (6MWT), London Chest Activity of Daily Living Scale (LCADL), Hospital anxiety and depression Scale, modified Medical Research Council Scale (mMRC), Saint George Respiratory Questionnaire (SGRQ), and respiratory and peripheral muscle strength [manovacuometry and 1-repetition maximum test (quadriceps femoris, biceps and triceps brachialis), respectively]. ACO was defined according to Sin et al. (Eur Respir J 48(3):664-673, 2016). RESULTS: The sample was composed of 74 subjects (57% male, age 67 ± 8 years, BMI 26 (21-32) kg/m2, FEV1 47 ± 17%predicted), and 12 (16%) of them were classified as presenting ACO. Both groups improved pulmonary function, 6MWT, peripheral and inspiratory muscle strength, LCADL, and SGRQ after ET (p < 0.005 for all). There were no significant interactions between ACO and COPD on ET effects (p > 0.05 for all). Likewise, there was no difference in the proportion of patients achieving the minimum clinical important difference for 6MWT and mMRC. CONCLUSION: High-intensity exercise training generates similar benefits in patients with COPD regardless of whether presenting asthma overlap or not.


Subject(s)
Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome/rehabilitation , Exercise Therapy/methods , Pulmonary Disease, Chronic Obstructive/rehabilitation , Activities of Daily Living , Aged , Anxiety/psychology , Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome/physiopathology , Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome/psychology , Body Composition , Depression/psychology , Electric Impedance , Female , Forced Expiratory Volume , Humans , Male , Middle Aged , Muscle Strength , Pulmonary Disease, Chronic Obstructive/physiopathology , Pulmonary Disease, Chronic Obstructive/psychology , Resistance Training/methods , Spirometry , Treatment Outcome , Vital Capacity , Walk Test
10.
Lung ; 197(4): 509-516, 2019 08.
Article in English | MEDLINE | ID: mdl-31079224

ABSTRACT

PURPOSE: Whether the difference in the impact of chronic obstructive pulmonary disease (COPD) on the functional status of men and women stems from clinical distinctions or to the measuring instrument used is unclear. Like most instruments for assessing functional limitation in COPD, the interpretation of the results of the London Chest Activity of Daily Living (LCADL) scale is limited because a lack of a valid cutoff point to this scale. For that, this study sought to compare the functional status between men and women with COPD; and propose a cutoff point for LCADL capable of discriminating the prognosis of these individuals. METHODS: A sample of 138 subjects with moderate-severe COPD was evaluated by the LCADL. The percentage of the individual maximum score was used to obtain a cutoff point capable of discriminating patients with the worse prognosis according to the BODE Index. The cutoff point was also tested in an independent sample (n = 70). RESULTS: Regarding the total score, domestic and leisure domains of the LCADL, men had better scores than women (P ≤ 0.01). The cutoff point found was 37% (area under the curve = 0.70, 95% confidence interval = 0.60-0.80, sensitivity = 0.55 and specificity = 0.74). Individuals who scored ≥ 37% had a worse prognosis and level of physical activities of daily living than those who scored below (P ≤ 0.02). CONCLUSION: When evaluated by the LCADL, men and women with COPD present difference in the functional status. The established cutoff point (37%) adequately discriminates individuals regarding the prognosis, contributing to improve the interpretation capacity of the LCADL.


Subject(s)
Activities of Daily Living , Lung/physiopathology , Pulmonary Disease, Chronic Obstructive/diagnosis , Aged , Cross-Sectional Studies , Female , Health Status , Humans , Male , Middle Aged , Predictive Value of Tests , Pulmonary Disease, Chronic Obstructive/physiopathology , Reproducibility of Results , Retrospective Studies , Severity of Illness Index , Sex Factors
11.
Lung ; 197(1): 9-13, 2019 02.
Article in English | MEDLINE | ID: mdl-30374589

ABSTRACT

The aim of the study was to investigate the relationship between slow and forced vital capacity (SVC-FVC) difference with dynamic lung hyperinflation (DH) during the 6-min walking test (6MWT) in subjects with chronic obstructive pulmonary disease (COPD). Twenty-four subjects with COPD (12 males; 67 ± 6 years; forced expiratory volume in first second [FEV1] 56 ± 18% predicted) performed lung function tests by spirometry and plethysmography. DH was assessed by serial measurements of inspiratory capacity (IC) performed during the 6MWT and defined as ∆IC ≥ 150 mL or 10%. IC decrease significantly during the 6MWT (ΔCI: - 0.48 ± - 0.40 L; P < 0.0001), and 18 individuals (75%) presented DH. There was significant difference when comparing IC measured at rest with the other serial IC measurements (P < 0.0001). Correlation between the SVC-FVC difference and DH during the 6MWT was r = - 0.38; P = 0.06. The SVC-FVC difference presented only weak correlation with the development of DH during the 6MWT in patients with COPD.


Subject(s)
Lung/physiopathology , Pulmonary Disease, Chronic Obstructive/physiopathology , Vital Capacity , Aged , Cross-Sectional Studies , Exercise Tolerance , Female , Forced Expiratory Volume , Humans , Male , Middle Aged , Plethysmography , Pulmonary Disease, Chronic Obstructive/diagnosis , Spirometry , Time Factors , Walk Test
12.
Fisioter. Pesqui. (Online) ; 25(1): 43-48, jan.-mar. 2018. tab
Article in Portuguese | LILACS | ID: biblio-892163

ABSTRACT

RESUMO Este estudo analisa a atividade física na vida diária (AFVD) de pacientes com doença pulmonar obstrutiva crônica (DPOC), quantificada em três diferentes períodos de uso diário do sensor de movimento: 8 horas, 12 horas e período de tempo acordado, a fim de identificar se os desfechos de AFVD diferem entre si. Trata-se de um estudo transversal com 45 pacientes (66±8 anos) classificados com DPOC de moderada a grave. A AFVD foi avaliada utilizando-se o monitor de atividade física SenseWear Armband (SAB) durante 7 dias consecutivos, 24 horas por dia. Compararam-se os resultados de AFVD fornecidos pelo monitor nos três períodos de avaliação dentro das 24 horas de uso. Os desfechos de sedentarismo e de atividade física (número de passos e gasto energético total) foram diferentes nos três períodos de utilização do SAB, com maiores valores na avaliação por período de tempo acordado. Quanto aos desfechos de atividade física estratificados por idade - 3 ou 2 equivalentes metabólicos (MET) -, os resultados foram similares na avaliação por 12 horas e por período de tempo acordado. Concluiu-se, afinal, que o uso do monitor de atividade física durante o tempo acordado é o desfecho mais indicado para monitoração acurada e completa de sedentarismo e atividade física em pacientes com DPOC.


RESUMEN Este estudio analiza la actividad física en la vida diaria (AFVD) de pacientes con enfermedad pulmonar obstructiva crónica (EPOC), cuantificada en tres distintos períodos de uso diario del sensor de movimiento: 8 horas, 12 horas y el período de tiempo despierto, con la finalidad de identificar si los resultados de AFVD difieren entre sí. Se trata de un estudio transversal con 45 pacientes (66±8 años) clasificados con EPOC de moderada a grave. La AFVD ha sido evaluada con la utilización del monitor de actividad física SenseWear Armband® (SAB) durante 7 días consecutivos, las 24 horas del día. Se han comparado los resultados de AFVD suministrados por el monitor en los tres períodos de evaluación dentro de las 24 horas de uso. Los resultados de sedentarismo y de actividad física (el número de pasos y de gasto energético total) han sido distintos en los tres períodos de utilización del SAB, con valores más grandes en la evaluación por período de tiempo despierto. Cuanto a los resultados de la actividad física estratificadas por edad - 3 o 2 equivalentes metabólicos (METs) -, los resultados han sido similares en la evaluación por 12 horas y por el período de tiempo despierto. Se ha concluido, por fin, que el uso del monitor de la actividad física durante el tiempo despierto es el resultado más indicado para el monitoreo preciso y completo de sedentarismo y de la actividad física en pacientes con EPOC.


ABSTRACT This study analyzes physical activity in the daily lives (PADL) of patients with chronic obstructive pulmonary disease (COPD), measured in three different periods of daily use of motor sensor: 8 hours, 12 hours, and awake time, in order to identify if the PADL outcomes are different among each other. It is a transversal study with 45 patients (66±8 years) classified as having moderate to severe COPD. The PADL was assessed using the physical activity monitor SenseWear Armband (SAB) for 7 consecutive days, 24 hours a day. The PADL results provided by the monitor in the three evaluation periods within 24 hours of use were compared. The sedentary and physical activity outcomes (number of steps and total energy expenditure) were different in the three periods using the SAB, having higher values in the assessment per awake time. Regarding the physical activity outcomes divided into age groups - 3 or 2 metabolic equivalents (METs) -, the outcomes were similar to the evaluation for 12 hours and per awake time. It was concluded, thus, that the use of physical activity monitor during the awake time is the most indicated outcome for accurate and complete monitoring of sedentarism and physical activity in COPD patients.

SELECTION OF CITATIONS
SEARCH DETAIL
...